CN103263518A - Traditional Chinese medicine composition capable of promoting wound healing after thoracic operation - Google Patents
Traditional Chinese medicine composition capable of promoting wound healing after thoracic operation Download PDFInfo
- Publication number
- CN103263518A CN103263518A CN201310223350XA CN201310223350A CN103263518A CN 103263518 A CN103263518 A CN 103263518A CN 201310223350X A CN201310223350X A CN 201310223350XA CN 201310223350 A CN201310223350 A CN 201310223350A CN 103263518 A CN103263518 A CN 103263518A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- wound healing
- traditional chinese
- fructus crataegi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition capable of promoting wound healing after a thoracic operation. The traditional Chinese medicine composition comprises the following raw materials prepared into active ingredients: 30-40% of astragalus membranaceus, 10-12% of angelica sinensis, 8-10% of colla corii asini, 10-14% of pseudo-ginseng, 5-8% of wined ligusticum wallichii, 7-10% of parched hawthorn fruit, 3-5% of raw hawthorn fruit, 10-12% of endothelium corneum gigeriae galli, and 5-8% of pericarpium citri reticulatae, wherein the total mass content of the raw materials is 100%. The traditional Chinese medicine composition disclosed by the invention is capable of effectively eliminating local extravasated blood, chest-hypochondrium pain, and spleen-stomach deficiency after the thoracic operation, and rapidly promoting wound healing, physical rehabilitation and vitality recovery.
Description
Technical field
The invention belongs to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine composition that promotes the thoracic postop wound healing.
Background technology
Modern life rhythm is accelerated, and increasing people is swamped with in daily life, and surfeit is pungent greasy, greasy and surfeit flavour, the raw food barbecue, tobacco and wine are excessive in addition, unhappy, it is irregular to live, and causes the occurred frequently of multiple disease, as pulmonary carcinoma, the esophageal carcinoma, mesothelioma of pleura etc., this class disease is once making a definite diagnosis, must perform the operation to save patient's life as early as possible, but this major operation often causes very big wound to body, physical recovery is slower.Because relevant body injuries such as anaesthetic effect in the operation, operation wound, if the permanent disunion of wound, severe complications such as postoperative pneumonia, pulmonary atelectasis, hydrothorax, thoracic cavity are hemorrhage, hemopneumothorax, broncho-pulmonary stump fistula, fistula of esophageal anastomosis appear in patient easily, increased the misery of patient and family thereof greatly, even entail dangers to patient's life.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine composition that promotes the thoracic postop wound healing, at the characteristics of thoracic postop wound wound, can effectively eliminate local congestion, pain in chest and hypochondrium, the weakness of the spleen and stomach of thoracic postop, promote wound healing fast, physical rehabilitation rebuilds one's physical constitution.
The technical solution adopted in the present invention is, a kind of Chinese medicine composition that promotes the thoracic postop wound healing, according to mass percent, it is as follows to make raw materials of effective components: the Radix Astragali 30%～40%, Radix Angelicae Sinensis 10%～12%, Colla Corii Asini bead 8%～10%, Radix Notoginseng 10%～14%, prepared RHIZOMA CHUAN XIONG with yellow rice wine 5%～8%, Fructus Crataegi (parched to brown) 7%～10%, Fructus Crataegi 3%～5%, Endothelium Corneum Gigeriae Galli 10%～12%, Pericarpium Citri Reticulatae 5%～8%, the quality summation content of above raw material is 100%.
Preferably, a kind of Chinese medicine composition that promotes the thoracic postop wound healing of the present invention, according to mass percent, it is as follows to make raw materials of effective components: the Radix Astragali 40%, Radix Angelicae Sinensis 10%, Colla Corii Asini bead 10%, Radix Notoginseng 10%, prepared RHIZOMA CHUAN XIONG with yellow rice wine 5%, Fructus Crataegi (parched to brown) 7%, Fructus Crataegi 3%, Endothelium Corneum Gigeriae Galli 10%, Pericarpium Citri Reticulatae 5%.
Among the present invention, concrete function is as follows in the present invention to make each raw material of effective ingredient:
The Radix Astragali is the dry root of the leguminous plant Radix Astragali, and is sweet in flavor and warm in property, returns the spleen lung meridian, and the polishing yang invigorating, is used for deficiency of both the splenic and pulmonary QI, and god is tired weak, sinking of QI of middle-JIAO, and energy promoting pus discharge and tissue regeneration strengthening, and for chest postoperative body void, the slow or of a specified duration routed person of not healing of wound recovery has good restitution.
When the dry root that is classified as umbrella section plant Radix Angelicae Sinensis, nature and flavor are sweet, hot, and are warm in nature, return liver, and the heart, spleen channel are enriched blood, invigorated blood circulation, pain relieving, and dispirited to postoperative blood deficiency, complexion, congestion is had a pain, the arthralgia pain numbness, abdominal pain due to deficiency of blooies etc. cooperate the Radix Astragali that very fast restitution is arranged.
Colla Corii Asini, for the skin of equine species donkey boils the solid blob of viscose that forms after floating the bubble unhairing, the Colla Corii Asini bead of selecting for use among the present invention is the Colla Corii Asini piece to be smashed with Pulvis concha Mactrae or Pu rhizome of chuanxiong powder fry into pearl usefulness, nature and flavor are sweet flat, return lung Liver and kidney warp, tonifying blood and arresting bleeding, the usefulness of nourishing YIN and moistening the lung.
Radix Notoginseng is the dry root of panax araliaceae plant, and bitter in the mouth sweet in flavor and warm in property is returned liver stomach warp, removing stasis to stop bleeding, and invigorating blood circulation is pain, hemorrhage for the chest post-surgical trauma, and the stasis of blood stagnates and swells and ache, and venation is obstructed, and wound healing has good effect.
Prepared RHIZOMA CHUAN XIONG with yellow rice wine, for the dry rhizome of umbrella section plant Rhizoma Chuanxiong is fried usefulness with wine, acrid in the mouth, warm in nature, return liver, gallbladder, pericardium channel, be gas medicine in the blood, blood-activating and qi-promoting, wind-expelling pain-stopping, for the chest postoperative blood stasis stagnation of QI, side of body rib is had a pain, and numb limbs and tense tendons has curative effect preferably.
Fructus Crataegi is the dry mature fruit of rosaceous plant Fructus Pyri Pashiae or Fructus Crataegi, chip drying, and nature and flavor are sweet, and tepor is returned the taste Liver Channel, and the parching to brown promoting digestion and removing stagnation is given birth to and is used blood circulation promoting and blood stasis dispelling, blood fat reducing.
Endothelium Corneum Gigeriae Galli is that the cutin inwall of Phasianidae animal man chicken peels off afterwash and dries, and not descend water, gives birth to for good, be subjected to hyperpyrexia can destroy gastric hormone during stir-fry, sweet, cold, return spleen, stomach, small intestinal, urinary bladder channel, activating the spleen helps digestion, controlling nocturnal emission with astringent drugs end to be lost, and still the merit that helps digestion of having heavily fortified point is usually used in treating anus skin ulcer (being that esophagus damages), promoting digestion and invigorating the stomach promotes gastrointestinal function to absorb.
Pericarpium Citri Reticulatae is given birth to usefulness for the drying and ripening fruit of rutaceae orange dries section, return the lung spleen channel, regulate the flow of vital energy to transfer, and drying dampness to eliminate phlegm, to the postoperative distension and fullness in the abdomen, belch vomiting and nausea, breast are coerced indigestion and loss of appetite asthenia good effect.
The present invention promotes the Chinese medicine composition of thoracic postop wound healing, adopts the conventional method of Chinese medicine preparation to make dosage forms such as decoction or capsule.
The invention has the beneficial effects as follows that all medicines share, benefiting qi and nourishing blood, promoting blood circulation to remove obstruction in the collateral, dredging the meridian helps the QI and blood growth, the warming the spleen stomach, can effectively eliminate local congestion, pain in chest and hypochondrium, the weakness of the spleen and stomach of thoracic postop, promote to repair damage, and the energy digestion-promoting and clot-absorbing, gastrointestinal function strengthened, the absorption that has additional nutrients makes the quick rehabilitation of patient body.
The specific embodiment
A kind of Chinese medicine composition that promotes the thoracic postop wound healing of the present invention, according to mass percent, it is as follows to make raw materials of effective components: the Radix Astragali 30%～40%, Radix Angelicae Sinensis 10%～12%, Colla Corii Asini bead 8%～10%, Radix Notoginseng 10%～14%, prepared RHIZOMA CHUAN XIONG with yellow rice wine 5%～8%, Fructus Crataegi (parched to brown) 7%～10%, Fructus Crataegi 3%～5%, Endothelium Corneum Gigeriae Galli 10%～12%, Pericarpium Citri Reticulatae 5%～8%, the quality summation content of above raw material is 100%.
Embodiment 1
The present invention promotes the Chinese medicine composition of thoracic postop wound healing, according to mass percent, it is as follows to make raw materials of effective components: the Radix Astragali 40%, Radix Angelicae Sinensis 10%, Colla Corii Asini bead 10%, Radix Notoginseng 10%, prepared RHIZOMA CHUAN XIONG with yellow rice wine 5%, Fructus Crataegi (parched to brown) 7%, Fructus Crataegi 3%, Endothelium Corneum Gigeriae Galli 10%, Pericarpium Citri Reticulatae 5%.
Preparation method and the using method of Chinese medicine composition of the present invention are: take by weighing above-mentioned raw materials according to mass percent, after it is evenly mixed, added the water logging bubble 0.5～1 of 2～3 times of volumes as a child, decoct 2 times, waste also mixes the medicinal liquid that obtains for twice.The medicinal liquid branch is taken for twice sooner or later, and 7 is a course for the treatment of.Perhaps, take by weighing above-mentioned raw materials according to mass percent, after it is evenly mixed, grind to form fine powder, make tablet or capsule according to conventional pharmaceutical technology.
Embodiment 2
The present invention promotes the Chinese medicine composition of thoracic postop wound healing, according to mass percent, it is as follows to make raw materials of effective components: the Radix Astragali 32%, Radix Angelicae Sinensis 11%, Colla Corii Asini bead 9%, Radix Notoginseng 12%, prepared RHIZOMA CHUAN XIONG with yellow rice wine 6%, Fructus Crataegi (parched to brown) 8%, Fructus Crataegi 4%, Endothelium Corneum Gigeriae Galli 11%, Pericarpium Citri Reticulatae 7%.
The preparation method of present embodiment and using method are with embodiment 1.
Embodiment 3
The present invention promotes the Chinese medicine composition of thoracic postop wound healing, according to mass percent, it is as follows to make raw materials of effective components: the Radix Astragali 30%, Radix Angelicae Sinensis 12%, Colla Corii Asini bead 8%, Radix Notoginseng 10%, prepared RHIZOMA CHUAN XIONG with yellow rice wine 8%, Fructus Crataegi (parched to brown) 10%, Fructus Crataegi 5%, Endothelium Corneum Gigeriae Galli 12%, Pericarpium Citri Reticulatae 5%.
The preparation method of present embodiment and using method are with embodiment 1.
Embodiment 4
The present invention promotes the Chinese medicine composition of thoracic postop wound healing, according to mass percent, it is as follows to make raw materials of effective components: the Radix Astragali 35%, Radix Angelicae Sinensis 10%, Colla Corii Asini bead 8%, Radix Notoginseng 14%, prepared RHIZOMA CHUAN XIONG with yellow rice wine 5%, Fructus Crataegi (parched to brown) 7%, Fructus Crataegi 3%, Endothelium Corneum Gigeriae Galli 10%, Pericarpium Citri Reticulatae 8%.
The preparation method of present embodiment and using method are with embodiment 1.
Use the present composition thoracic postop patient to be treated and the existing routine clinical doctor trained in Western medicine medication of combination, take present composition decoction according to the wound healing situation and be generally 1～3 course for the treatment of, be 7 each course for the treatment of, therapeutic effect is: total number of persons 61 people, cured person 32 people in 5 days after medication, cured person 17 people in 8 days after medication, cured person 10 people in 14 days after medication, cured person 2 people in medication 21 days.
Model case:
Mulberry, the woman, 46 years old, this patient was because suffering from mesothelioma of pleura, take the pleural decortication treatment, postoperative adopts conventional doctor trained in Western medicine medication, the wound surface disunion in 13 days of patient's postoperative, operative incision place redness, cyanosis, livid purple and ooze out the pale red hydrothorax from incision, patient's sharp ache, be positive position, can't descend ground movable, influence the recovery of the postoperative state of an illness.Leave hospital for promoting patient's early recovery, alleviate the patient suffering and reduce patient's household economy burden, cooperate the decoction take the present composition after 2 courses for the treatment of, thoracic incision swelling obviously alleviates, symptoms such as livid purple and cyanosis are clearly better, pain disappears, and no food stagnation is stagnated, mechanism of qi is obstructed sensation, the wound surface healing.
Liu, man, 67 years old, this patient is weak, because suffering from the esophageal carcinoma, takes esophagus partly to excise esophagus and stomach apparatus formula anastomosis, postoperative is because operating time is long, patient's wound is bigger, and is old, and needs the postoperative fasting, patient's postoperative nutritional status is relatively poor, and postoperative wound surface healing in 15 days is slow, still has the operative incision sepage, and a little less than the empty gas of body, take the decoction of the present composition after 3 courses for the treatment of, have a good complexion, the growth of edge of wound granulation is obvious, the wound surface healing.
Claims (2)
1. Chinese medicine composition that promotes the thoracic postop wound healing, it is characterized in that, according to mass percent, it is as follows to make raw materials of effective components: the Radix Astragali 30%～40%, Radix Angelicae Sinensis 10%～12%, Colla Corii Asini bead 8%～10%, Radix Notoginseng 10%～14%, prepared RHIZOMA CHUAN XIONG with yellow rice wine 5%～8%, Fructus Crataegi (parched to brown) 7%～10%, Fructus Crataegi 3%～5%, Endothelium Corneum Gigeriae Galli 10%～12%, Pericarpium Citri Reticulatae 5%～8%, the quality summation content of above raw material is 100%.
2. according to the Chinese medicine composition of the described promotion thoracic postop of claim 1 wound healing, it is characterized in that, according to mass percent, it is as follows to make raw materials of effective components: the Radix Astragali 40%, Radix Angelicae Sinensis 10%, Colla Corii Asini bead 10%, Radix Notoginseng 10%, prepared RHIZOMA CHUAN XIONG with yellow rice wine 5%, Fructus Crataegi (parched to brown) 7%, Fructus Crataegi 3%, Endothelium Corneum Gigeriae Galli 10%, Pericarpium Citri Reticulatae 5%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310223350.XA CN103263518B (en) | 2013-06-06 | 2013-06-06 | Traditional Chinese medicine composition capable of promoting wound healing after thoracic operation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310223350.XA CN103263518B (en) | 2013-06-06 | 2013-06-06 | Traditional Chinese medicine composition capable of promoting wound healing after thoracic operation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103263518A true CN103263518A (en) | 2013-08-28 |
| CN103263518B CN103263518B (en) | 2014-11-12 |
Family
ID=49007212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310223350.XA Expired - Fee Related CN103263518B (en) | 2013-06-06 | 2013-06-06 | Traditional Chinese medicine composition capable of promoting wound healing after thoracic operation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103263518B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102657795A (en) * | 2012-05-20 | 2012-09-12 | 纪磊 | Traditional Chinese medicine preparation for promoting postoperative incision healing |
-
2013
- 2013-06-06 CN CN201310223350.XA patent/CN103263518B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102657795A (en) * | 2012-05-20 | 2012-09-12 | 纪磊 | Traditional Chinese medicine preparation for promoting postoperative incision healing |
Non-Patent Citations (2)
| Title |
|---|
| 张欢: "《手术切口脂肪液化的药物治疗》", 《中国药师》, vol. 12, no. 5, 31 December 2009 (2009-12-31), pages 578 - 580 * |
| 颜燕艮等: "《古籍文献中以生肌类功效命名的外用古方浅析》", 《广州中医药大学学报》, vol. 19, no. 3, 30 September 2002 (2002-09-30), pages 234 - 235 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103263518B (en) | 2014-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103007191B (en) | Chinese medicinal composition for treating jaundice | |
| CN104873947A (en) | Medicinal composition for treating dog acute upper gastrointestinal hemorrhage and preparation method thereof | |
| CN104758953A (en) | Gastrointestinal tract contrast agent | |
| CN103316317A (en) | Traditional Chinese medicine composition for treating superficial gastritis | |
| CN104435326A (en) | Traditional Chinese medicine preparation for treating acute mastitis | |
| CN103212020B (en) | Traditional Chinese medicine composition for treating functional dyspepsia | |
| CN101856441A (en) | Medicament for treating acne and comedo and preparation method thereof | |
| CN106421053A (en) | Traditional Chinese medicine capable of tonifying spleen and warming stomach | |
| CN103212026B (en) | A kind of Chinese medicine for the treatment of cholelithiasis and preparation method thereof and instructions of taking | |
| CN102908580B (en) | Traditional Chinese medicine composition for treating woman metrorrhagia and preparation method of traditional Chinese medicine composition | |
| CN103263518B (en) | Traditional Chinese medicine composition capable of promoting wound healing after thoracic operation | |
| CN104042839A (en) | Traditional Chinese medicine composition for treating tinea versicolor | |
| CN104489688A (en) | Healthcare medicated food for alleviating side reaction of hepatic and renal function damage caused by chemotherapy and preparation method of healthcare medicated food | |
| CN104352808A (en) | Traditional Chinese medicine water-honeyed pills for treating ovarian cancer | |
| CN102406915A (en) | Traditional Chinese medicine composition for treating gastroenteritis | |
| CN102670773A (en) | Chinese herba preparation for treating scleroderma | |
| CN101757156A (en) | Medicament for treating long-term low-grade fever and preparation method thereof | |
| CN102698013A (en) | Tablets for treating traumatic injury and fracture dislocation | |
| CN105169040A (en) | Medicine for treating postpartum kidney and blood deficiency and preparation method thereof | |
| CN103977213A (en) | Health care medicine for treating spleen and stomach deficiency-cold type chronic gastritis | |
| CN104491587A (en) | Medicament for relieving side effects of damaging liver and kidney functions due to chemotherapy and preparation method thereof | |
| CN104547930A (en) | Heat-clearing and diuresis-promoting medicament for spleen-deficiency and dampness-heat type jaundice hepatitis and preparation method | |
| CN104587079B (en) | Compound osteomyelitis ball | |
| CN104758861A (en) | Dysphagia treating drug | |
| CN103028104B (en) | Traditional Chinese medicine composition for treating abdominal pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: THE 4TH MILITARY SURGEON UNIV. P. L. A. Free format text: FORMER OWNER: LU QIANG Effective date: 20150212 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 710038 XI'AN, SHAANXI PROVINCE TO: 710032 XI'AN, SHAANXI PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20150212 Address after: 710032 Changle West Road, Shaanxi, No. 169 West Road, Xi'an Patentee after: The Fourth Military Medical University of the Chinese People's Liberation Army Address before: 710038 room 21, building 10, 406 Temple Road, Baqiao District, Shaanxi, Xi'an, China Patentee before: Lu Qiang |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141112 Termination date: 20160606 |